123 related articles for article (PubMed ID: 30677774)
21. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
[TBL] [Abstract][Full Text] [Related]
22. [The role of AT1 receptor and cyclin kinase inhibitor p27 protein in angiotensin II-induced hypertrophy of mesangial cell].
Mei X; Gao C; Cui R
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):609-12. PubMed ID: 11758242
[TBL] [Abstract][Full Text] [Related]
23. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
24. 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
Ma J; Natarajan R; LaPage J; Lanting L; Kim N; Becerra D; Clemmons B; Nast CC; Surya Prakash GK; Mandal M; Adler SG
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):13-20. PubMed ID: 15589395
[TBL] [Abstract][Full Text] [Related]
25. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.
Yuan H; Lanting L; Xu ZG; Li SL; Swiderski P; Putta S; Jonnalagadda M; Kato M; Natarajan R
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F605-17. PubMed ID: 18562637
[TBL] [Abstract][Full Text] [Related]
26. Macrophage 12(S)-HETE Enhances Angiotensin II-Induced Contraction by a BLT2 (Leukotriene B
Kriska T; Herrnreiter A; Pfister SL; Adebesin A; Falck JR; Campbell WB
Hypertension; 2022 Jan; 79(1):104-114. PubMed ID: 34784723
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Histone Lysine Methylation in p21 Gene Expression in Rat Kidney In Vivo and Rat Mesangial Cells In Vitro under Diabetic Conditions.
Li X; Li C; Li X; Cui P; Li Q; Guo Q; Han H; Liu S; Sun G
J Diabetes Res; 2016; 2016():3853242. PubMed ID: 27652271
[TBL] [Abstract][Full Text] [Related]
30. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway.
Scheidegger KJ; Butler S; Witztum JL
J Biol Chem; 1997 Aug; 272(34):21609-15. PubMed ID: 9261183
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
33. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid.
Zhu M; Natarajan R; Nadler JL; Moore JM; Gelband CH; Sumners C
J Neurophysiol; 2000 Nov; 84(5):2494-501. PubMed ID: 11067992
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle regulation in diabetic nephropathy.
Wolf G
Kidney Int Suppl; 2000 Sep; 77():S59-66. PubMed ID: 10997692
[TBL] [Abstract][Full Text] [Related]
38. Renin response to 12-hydroxyeicosatetraenoic acid is increased in diabetic rats.
Antonipillai I; Jost-Vu E; Natarajan R; Nadler J; Horton R
Diabetes; 1995 Mar; 44(3):321-5. PubMed ID: 7533733
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
[TBL] [Abstract][Full Text] [Related]
40. Evidence that angiotensin II and lipoxygenase products activate c-Jun NH2-terminal kinase.
Wen Y; Scott S; Liu Y; Gonzales N; Nadler JL
Circ Res; 1997 Nov; 81(5):651-5. PubMed ID: 9351437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
